Variant report
Variant | esv3406974 |
---|---|
Chromosome Location | chr9:84898447-84923322 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FAM75D1-4 | chr9:84912297-84912455 | ENSG00000228430.4 |
2 | lnc-FAM75D1-4 | chr9:84912297-84912455 | ENSG00000228430.4 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000228430 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568681886 | chr9:84898453-84898454 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs146982838 | chr9:84898472-84898473 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs112441756 | chr9:84898510-84898511 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs565517303 | chr9:84898581-84898582 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs138151472 | chr9:84898584-84898585 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs113191563 | chr9:84898587-84898588 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs368314346 | chr9:84898588-84898589 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs143199561 | chr9:84898612-84898613 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs543360336 | chr9:84898682-84898683 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs189689272 | chr9:84898687-84898688 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs573815177 | chr9:84898688-84898689 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs541938559 | chr9:84898725-84898726 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs560608424 | chr9:84898733-84898734 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs113528349 | chr9:84898764-84898765 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs182533106 | chr9:84898772-84898773 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs564472641 | chr9:84898780-84898781 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs35631969 | chr9:84898816-84898817 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs397771220 | chr9:84898817-84898818 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs386415277 | chr9:84898818-84898819 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs112713855 | chr9:84898879-84898880 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs78779530 | chr9:84898948-84898949 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs141395101 | chr9:84899042-84899043 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs189242324 | chr9:84899046-84899047 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs150826450 | chr9:84899132-84899133 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs111565926 | chr9:84899195-84899196 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs117112233 | chr9:84899197-84899198 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs550959523 | chr9:84899220-84899221 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs73465472 | chr9:84899291-84899292 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs536932792 | chr9:84899320-84899321 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs138268923 | chr9:84899329-84899330 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs543249354 | chr9:84899332-84899333 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs142897692 | chr9:84899387-84899388 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs567383552 | chr9:84899411-84899412 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs146118541 | chr9:84899562-84899563 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs78888943 | chr9:84899578-84899579 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs193060592 | chr9:84899590-84899591 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs564463119 | chr9:84899591-84899592 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs28469416 | chr9:84899599-84899600 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs543735973 | chr9:84899615-84899616 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs562376944 | chr9:84899625-84899626 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs113908394 | chr9:84899692-84899693 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs529575663 | chr9:84899700-84899701 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs112010614 | chr9:84899746-84899747 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs74614582 | chr9:84899760-84899761 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs549599030 | chr9:84899808-84899809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185432252 | chr9:84899922-84899923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551096688 | chr9:84899999-84900000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs569289260 | chr9:84900000-84900001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs144822151 | chr9:84900051-84900052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs548719999 | chr9:84900055-84900056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Astrocytoma | 22246337 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Epilepsy | 20502679 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:84890600-84899600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr9:84890800-84899800 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
3 | chr9:84896400-84898600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr9:84896400-84898800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr9:84898600-84899400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr9:84898800-84899800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr9:84899600-84900200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr9:84899800-84900200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
9 | chr9:84909800-84910200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
10 | chr9:84909800-84911400 | Enhancers | Skeletal Muscle Male | skeletal muscle |
11 | chr9:84910200-84911200 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
12 | chr9:84910400-84910800 | Enhancers | Colon Smooth Muscle | Colon |
13 | chr9:84911200-84911600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
14 | chr9:84917800-84918200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
15 | chr9:84918000-84918400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr9:84918000-84919000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr9:84918200-84918600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr9:84923000-84923600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
19 | chr9:84923200-84923600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |